The impact of healthcare policy decisions/non-decisions weighs heavily on patients. With the advent of the Affordable Care Act more people can received health insurance. However, more must not only pay more than in the past but must pay close attention to details of what they are buying and receiving. Many states are discussing and enacting legislation for the purpose of considering patient needs. The APPS (autoimmune patient policy summit) presented by the Autoimmune Advocacy Alliance – A3 hoped to clarify what is happening in Washington State.
Beginning with the most current science impacting healthcare, Jane Buckner, MD and Associate Director of Benaroya Research Institute talked about how research continues to address chronic diseases. Other key subjects included a discussion of biologics/biosimilars, health plan transparency and the effect of out-of-pocket expenses.
The Vision was given to Erin Dziedzic, Dziedzic Public Affairs by A3 for leadership in advancing quality issues for patients.